ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIBC With Papillary-Only Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. SYNA
2. ON
3. SPY
4. LFTO
5. QNT
6. MU
7. ACAD
8. AAPL
9. SPCX
10. NKE

Go back to ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIBC With Papillary-Only Disease
(NASDAQ: IBRX) Delayed: 8.71 --0 (-0%)
Previous Close $8.71    52 Week High $ 
Open $8.71    52 Week Low $ 
Day High $8.71    P/E N/A 
Day Low $8.71    EPS $ 
Volume 48,734